Total Payments
$1,397
2024 Payments
$425.92
Companies
23
Transactions
59
Medicare Patients
3,277
Medicare Billing
$298,495
Payment Breakdown by Category
Food & Beverage$1,397 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,397 | 59 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Aries Pharmaceuticals, Inc. | $270.74 | 2 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $193.49 | 10 | $0 (2024) |
| Celgene Corporation | $105.15 | 6 | $0 (2023) |
| PFIZER INC. | $93.29 | 5 | $0 (2023) |
| Olympus America Inc. | $89.30 | 6 | $0 (2019) |
| Biohaven Pharmaceutical Holding Company Ltd. | $83.77 | 4 | $0 (2022) |
| Xeris Pharmaceuticals, Inc. | $77.79 | 3 | $0 (2024) |
| ABBVIE INC. | $56.82 | 3 | $0 (2024) |
| Exact Sciences Corporation | $51.53 | 3 | $0 (2023) |
| Abbott Laboratories | $49.13 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $425.92 | 21 | Takeda Pharmaceuticals U.S.A., Inc. ($161.48) |
| 2023 | $361.84 | 18 | PFIZER INC. ($93.29) |
| 2022 | $210.92 | 10 | Biohaven Pharmaceutical Holding Company Ltd. ($83.77) |
| 2019 | $30.66 | 2 | Olympus America Inc. ($30.66) |
| 2018 | $340.74 | 7 | Aries Pharmaceuticals, Inc. ($270.74) |
| 2017 | $26.55 | 1 | Covidien LP ($26.55) |
All Payment Transactions
59 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/12/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 10/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $32.00 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/25/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.42 | General |
| Category: PSYCHIATRY | ||||||
| 09/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/12/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $35.75 | General |
| Category: LIVER DISEASE | ||||||
| 09/11/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 08/30/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $39.82 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 07/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Respiratory | ||||||
| 06/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/27/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Rare Disease | ||||||
| 06/05/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $25.41 | General |
| Category: Iron Deficiency Anemia | ||||||
| 05/01/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Diabetes | ||||||
| 04/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: IMMUNOLOGY | ||||||
| 04/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $8.88 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $7.03 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/01/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: IMMUNOLOGY | ||||||
| 02/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $8.51 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/26/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: IMMUNOLOGY | ||||||
| 11/28/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $32.01 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/22/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.52 | General |
| Category: Neuroscience | ||||||
| 11/03/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $35.06 | General |
| Category: Immunology | ||||||
| 10/31/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 642 | 650 | $621,306 | $74,005 |
| 2022 | 10 | 547 | 563 | $441,058 | $49,636 |
| 2021 | 15 | 866 | 893 | $701,965 | $72,274 |
| 2020 | 19 | 1,222 | 1,280 | $864,529 | $102,580 |
Total Patients
3,277
Total Services
3,386
Medicare Billing
$298,495
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 187 | 189 | $156,492 | $35,490 | 22.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 247 | 249 | $246,759 | $19,393 | 7.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 139 | 143 | $160,875 | $8,967 | 5.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 34 | 34 | $18,870 | $6,127 | 32.5% |
| 45388 | Destruction of polyp or growth of large bowel using a flexible endoscope | Facility | 2023 | 17 | 17 | $20,400 | $3,792 | 18.6% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Facility | 2023 | 18 | 18 | $17,910 | $235.06 | 1.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 84 | 84 | $85,563 | $16,014 | 18.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 153 | 153 | $165,663 | $14,916 | 9.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 132 | 136 | $148,041 | $8,756 | 5.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 19 | 19 | $9,915 | $3,485 | 35.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 49 | 52 | $4,056 | $1,989 | 49.0% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 12 | 12 | $11,109 | $1,486 | 13.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 13 | 22 | $3,673 | $1,184 | 32.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 11 | 11 | $3,421 | $1,171 | 34.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 13 | 13 | $1,443 | $442.92 | 30.7% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2022 | 61 | 61 | $8,174 | $192.46 | 2.4% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 88 | 88 | $113,256 | $17,127 | 15.1% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 144 | 144 | $176,400 | $15,731 | 8.9% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 96 | 99 | $102,762 | $8,353 | 8.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 37 | 37 | $17,649 | $6,783 | 38.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 91 | 106 | $8,366 | $5,132 | 61.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 42 | 43 | $13,373 | $4,705 | 35.2% |
| 45388 | Destruction of tissue abnormalities, tumors, or polyps of large bowel using a flexible endoscope | Facility | 2021 | 21 | 21 | $204,288 | $4,620 | 2.3% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 15 | 15 | $14,355 | $1,921 | 13.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 23 | 31 | $5,146 | $1,765 | 34.3% |
About Dr. Vu Le, MD
Dr. Vu Le, MD is a Internal Medicine healthcare provider based in Union Gap, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/07/2007. The National Provider Identifier (NPI) number assigned to this provider is 1912047051.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vu Le, MD has received a total of $1,397 in payments from pharmaceutical and medical device companies, with $425.92 received in 2024. These payments were reported across 59 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($1,397).
As a Medicare-enrolled provider, Le has provided services to 3,277 Medicare beneficiaries, totaling 3,386 services with total Medicare billing of $298,495. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology
- Location Union Gap, WA
- Active Since 02/07/2007
- Last Updated 04/07/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1912047051
Products in Payments
- ELEVIEW (Device) $270.74
- ENTYVIO (Biological) $165.38
- ZEPOSIA (Drug) $105.15
- NURTEC ODT (Drug) $102.59
- RECORLEV (Drug) $64.01
- RINVOQ (Biological) $56.82
- Cologuard Collection Kit (Device) $51.53
- REXULTI (Drug) $41.63
- RESMETIROM (Drug) $35.75
- PAXLOVID (Drug) $35.29
- STELARA (Biological) $35.06
- Olympus Tissue Acquisition Devices (Device) $32.47
- Olympus Hemostasis Devices (Device) $30.66
- GATTEX (Drug) $28.11
- Manometry (Device) $26.55
- Olympus GI Accessories (Device) $26.17
- INJECTAFER (Drug) $25.41
- FREESTYLE LIBRE 2 (Device) $24.70
- FREESTYLE LIBRE (Device) $24.43
- FASENRA (Biological) $24.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.